Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This trial is conducted in Europe. The aim of the trial is to evaluate the optimal dosing conditions for semaglutide (a long acting GLP-1 analogue) in healthy male subjects.
Epistemonikos ID: aafd50fb03b9236370b6b84a1900370519c88610
First added on: May 10, 2024